We serve Chemical Name:N-(4-chloro-3-iodopyridin-2-yl)pivalamide CAS:898561-61-0 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:N-(4-chloro-3-iodopyridin-2-yl)pivalamide
CAS.NO:898561-61-0
Synonyms:N-(4-chloro-3-iodopyridin-2-yl)-2,2-dimethylpropanamide;Propanamide, N-(4-chloro-3-iodo-2-pyridinyl)-2,2-dimethyl-;N-(4-Chloro-3-iodo-2-pyridinyl)-2,2-dimethylpropanamide
Molecular Formula:C10H12ClIN2O
Molecular Weight:338.573
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:419.1±45.0 °C at 760 mmHg
Density:1.7±0.1 g/cm3
Index of Refraction:1.623
PSA:41.99000
Exact Mass:337.968262
LogP:3.01
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:
Contact us for information like N-(4-chloro-3-iodopyridin-2-yl)-2,2-dimethylpropanamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-(4-Chloro-3-iodo-2-pyridinyl)-2,2-dimethylpropanamide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(4-Chloro-3-iodo-2-pyridinyl)-2,2-dimethylpropanamide Use and application,N-(4-chloro-3-iodopyridin-2-yl)-2,2-dimethylpropanamide technical grade,usp/ep/jp grade.
Related News: Symonds’ board has backed Walmsley’s leadership. In response to Elliott’s open attack earlier this month, the GSK board said it “strongly believes” Walmsley is the “right leader” for the company, citing “widespread and strong support” from GSK’s largest shareholders for Walmsley’s newly unveiled plan to improve the company’s performance. 2-(4-Chloro-phenoxy)-N-methoxy-2-methyl-propionamide manufacturers TULIP-2 demonstrated superiority across multiple efficacy endpoints versus placebo with both arms receiving standard therapy. yadanzioside D aglycone suppliers The US-based study is evaluating the effect of ensifentrine on key outcomes in patients hospitalised with COVID-19, including facilitation of recovery from the viral infection, clinical status improvement and reduction in supplemental oxygen use and progression to mechanical ventilation. 8-Decen-4-ol, 5-ethenylidene-8-methyl-, (E)- vendor & factory.
